[company_age]29.0[/company_age][employees]501-1000 employees[/employees][funding]post_ipo_equity[/funding][description]Rockwell Medical is a leading provider of hemodialysis products and services, dedicated to improving the lives of patients with end-stage kidney disease. The company's mission is to deliver life-sustaining dialysis solutions through high-quality products and exceptional customer service. Rockwell Medical's products are manufactured under strict cGMP regulations, ensuring the highest standards of safety and efficacy. The company's commitment to innovation and patient care sets it apart from its competitors. Rockwell Medical's Dry Acid Concentrate Mixer is a unique and innovative product that enables dialysis clinics to mix acid concentrate on-site, providing greater flexibility and convenience. The company's comprehensive product portfolio includes CitraPure®, Dri-Sate®, RenalPure®, and SteriLyte®, all of which are designed to meet the specific needs of hemodialysis patients. Rockwell Medical's strong focus on customer service ensures that its clients receive the support and guidance they need to optimize their dialysis treatments. The company's commitment to quality, innovation, and patient care has made it a trusted partner for dialysis clinics and patients worldwide.[/description][ps]Hemodialysis products, including dry and liquid citric acid, acetic acid, and bicarbonate concentrates, as well as the Dry Acid Concentrate Mixer.[/ps]